These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy. Kobayashi M; Takemoto Y; Norioka N; Iguchi T; Shimada K; Maeda M; Morimura M; Fujio Y; Azuma J; Yoshiyama M; Hirohashi K; Shuto T Osaka City Med J; 2015 Jun; 61(1):19-30. PubMed ID: 26434102 [TBL] [Abstract][Full Text] [Related]
8. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR; JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546 [TBL] [Abstract][Full Text] [Related]
14. Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol. Umeda A; Miyagawa K; Mochida A; Takeda H; Ohira Y; Kato T; Okada Y; Kotani K PLoS One; 2022; 17(11):e0277766. PubMed ID: 36449474 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial. Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702 [TBL] [Abstract][Full Text] [Related]
16. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist. Tonstad S J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731 [TBL] [Abstract][Full Text] [Related]
17. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial. Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931 [TBL] [Abstract][Full Text] [Related]
18. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210 [TBL] [Abstract][Full Text] [Related]
19. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840 [TBL] [Abstract][Full Text] [Related]
20. Nicotine preloading for smoking cessation: the Preloading RCT. Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]